(Q37950331)

English

Liver MRI in the hepatocyte phase with gadolinium-EOB-DTPA: does increasing the flip angle improve conspicuity and detection rate of hypointense lesions?

scientific article published on 27 October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 August 2017

Liver MRI in the hepatocyte phase with gadolinium-EOB-DTPA: does increasing the flip angle improve conspicuity and detection rate of hypointense lesions? (English)

1 reference

Europe PubMed Central

25 August 2017

0 references

magnetic resonance imaging

0 references

author name string

Mustafa R Bashir

1

1 reference

Europe PubMed Central

25 August 2017

Daniela B Husarik

2

1 reference

Europe PubMed Central

25 August 2017

Tim J Ziemlewicz

3

1 reference

Europe PubMed Central

25 August 2017

Rajan T Gupta

4

1 reference

Europe PubMed Central

25 August 2017

Daniel T Boll

5

1 reference

Europe PubMed Central

25 August 2017

Elmar M Merkle

6

1 reference

Europe PubMed Central

25 August 2017

publication date

27 October 2011

1 reference

Europe PubMed Central

25 August 2017

Journal of Magnetic Resonance Imaging

1 reference

Europe PubMed Central

25 August 2017

35

1 reference

Europe PubMed Central

25 August 2017

3

1 reference

Europe PubMed Central

25 August 2017

611-616

1 reference

Europe PubMed Central

25 August 2017

Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Gadolinium-enhanced MRI for tumor surveillance before liver transplantation: center-based experience.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Advanced MRI methods for assessment of chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Focal nodular hyperplasia: morphologic and functional information from MR imaging with gadobenate dimeglumine.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT--a multicenter trial.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging--correlation with expression of sinusoidal and canalicular transporters and bile accumulation

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Improved liver lesion conspicuity by increasing the flip angle during hepatocyte phase MR imaging.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatoce

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Consensus report of the 2nd International Forum for Liver MRI.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Gadoxetate disodium-enhanced MR imaging: differentiation between early-enhancing non-tumorous lesions and hypervascular hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Comparison of enhancement patterns of histologically confirmed hepatocellular carcinoma between gadoxetate- and ferucarbotran-enhanced magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Dynamic MR imaging of the biliary system using hepatocyte-specific contrast agents.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Measurement of signal-to-noise ratios in MR images: influence of multichannel coils, parallel imaging, and reconstruction filters.

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Assessment of hepatic extraction fraction and input relative blood flow using dynamic hepatocyte-specific contrast-enhanced MRI

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22850

21 January 2018

Identifiers

10.1002/JMRI.22850

1 reference

Europe PubMed Central

25 August 2017

1 reference

Europe PubMed Central

25 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37950331&oldid=1406268164"